DiaMedica Therapeutics(DMAC) - 2023 Q4 - Earnings Call Transcript

DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q4 2023 Results Conference Call March 20, 2024 8:00 AM ET Company Participants Dietrich Pauls - President, CEO & Director Lorianne Masuoka - Chief Medical Officer Scott Kellen - CFO & Company Secretary Conference Call Participants Thomas Flaten - Lake Street Capital François Brisebois - Oppenheimer Alex Nowak - Craig-Hallum Operator Good morning, ladies and gentlemen, and welcome to the DiaMedica Therapeutics Full Year 2023 Conference Call. An audio recording of the ...